投稿時間:2026-02-19 04:05:08 RSSフィード2026-02-19 04:00分まとめ(4件)
| カテゴリー | サイト名 | 記事タイトル | リンクURL | 頻出ワード・要約等 | 登録日 |
|---|---|---|---|---|---|
| AWS | AWS | BlueOcean is unlocking fast, focused marketing intelligence with Amazon Nova | Amazon Web Services | https://www.youtube.com/watch?v=WC5N8qfOqtQ | BlueOcean AI uses Amazon Nova to tailor AI to the task with fast inference when speed matters and reasoning when it counts See how they reduced tier processing time and optimized cost to empower marketers with AI driven brand intelligence Learn more about Subscribe to AWS Create a free AWS account Try AWS for free Connect with an expert Explore more Next steps Explore on AWS in Analyst Research Discover deploy and manage software that runs on AWS Join the AWS Partner Network Learn more on how Amazon builds and operates software Do you have technical AWS questions Ask the community of experts on AWS re Post Why AWS Amazon Web Services is the world s most comprehensive and broadly adopted cloud enabling customers to build anything they can imagine We offer the greatest choice of innovative cloud capabilities and expertise on the most extensive global infrastructure with industry leading security reliability and performance AmazonNova AWS GenerativeAI MarketingAI AgenticAI AmazonWebServices CloudComputing | 2026-02-18 18:08:31 |
| Program | JavaScriptタグが付けられた新着投稿 - Qiita | ページ内ポップアップを消して画像を取得するチャレンジやろうぜ | https://qiita.com/Xudev/items/76e8974acaf5f5d52fbb | クソアプリ,クソアプリアドカレ,チャレンジ | 2026-02-19 03:06:40 |
| 科学 | NYT > Science | N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up | https://www.nytimes.com/2026/02/18/us/politics/bhattacharya-kennedy-cdc-director.html | Dr Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention until President Trump appoints a permanent director | 2026-02-18 18:33:35 |
| 科学 | NYT > Science | F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine | https://www.nytimes.com/2026/02/18/health/fda-moderna-flu-vaccine-mrna.html | Moderna held further discussions with regulators and announced that the agency would accept the company s application for approval of its flu vaccine that uses mRNA technology | 2026-02-18 18:51:00 |
コメント
コメントを投稿